Literature DB >> 19217351

Optimizing outcomes of hematopoietic stem cell transplantation for severe combined immunodeficiency.

Geoff D E Cuvelier1, Kirk R Schultz, Jeff Davis, Aaron F Hirschfeld, Anne K Junker, Rusung Tan, Stuart E Turvey.   

Abstract

This FOCIS Centers of Excellence Short Analytical Review is based on the clinical vignette of two boys from the same family with very different outcomes following hematopoietic stem cell transplantation (HSCT) for X-linked severe combined immunodeficiency (SCID). We review the kinetics of immune reconstitution following HSCT in SCID and emphasize the latest information regarding optimizing transplant outcomes for this disorder. The cases illustrate the difficulties and controversies surrounding the optimal strategies for planning SCID transplants. Specifically, we will focus on 3 areas of current debate and investigation: (i) factors involved in donor selection; (ii) the role of pretransplant conditioning; and (iii) benefits of early HSCT for SCID.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217351     DOI: 10.1016/j.clim.2009.01.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  5 in total

1.  Postpartum HLA-Matched Bone Marrow Donation from Mother to Neonate for Reticular Dysgenesis.

Authors:  Gregory M T Guilcher; Nicola A M Wright; Tony H Truong; Andrew Daly; Victor A Lewis
Journal:  J Clin Immunol       Date:  2016-12-03       Impact factor: 8.317

Review 2.  Genetics of SCID.

Authors:  Fausto Cossu
Journal:  Ital J Pediatr       Date:  2010-11-15       Impact factor: 2.638

3.  Relevance of laboratory testing for the diagnosis of primary immunodeficiencies: a review of case-based examples of selected immunodeficiencies.

Authors:  Roshini S Abraham
Journal:  Clin Mol Allergy       Date:  2011-04-09

4.  The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients.

Authors:  Atar Lev; Amos J Simon; Mor Bareket; Bella Bielorai; Daphna Hutt; Ninette Amariglio; Gideon Rechavi; Raz Somech
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

5.  A novel, long-lived, and highly engraftable immunodeficient mouse model of mucopolysaccharidosis type I.

Authors:  Daniel C Mendez; Alexander E Stover; Anthony D Rangel; David J Brick; Hubert E Nethercott; Marissa A Torres; Omar Khalid; Andrew Ms Wong; Jonathan D Cooper; James V Jester; Edwin S Monuki; Cian McGuire; Steven Q Le; Shih-Hsin Kan; Patricia I Dickson; Philip H Schwartz
Journal:  Mol Ther Methods Clin Dev       Date:  2015-02-11       Impact factor: 6.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.